AbbVie · 2 weeks ago
Director II, eClinical Strategy
North Chicago, IL
Full-time
Onsite
Mid, Senior Level
$177K/yr - $336K/yr
5+ years expAbbVie is dedicated to discovering and delivering innovative medicines to address serious health issues. The Director II, eClinical Strategy will build and steward the next generation of e-Clinical Strategy with a focus on AI/Automation, ensuring an integrated clinical technology and data environment while facilitating collaboration across various stakeholders.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Builds and stewards the next generation of e-Clinical Strategy with AI/Automation, the 5Vs of clinical data generation/acquisition, the holistic end users experience, and an integrated clinical technology and data environment as its foundation
Supports interoperability across all internal functions, with clinical sites, with third-party contributors, and with our patients
Considers finance, operations, science, and all stakeholders as key areas of the eClinical strategy
Facilitates the convergence of technologies used for clinical trial planning and execution
Works to break down barriers between silos and provides an integrated and holistic view to end users
Bridges technology, process, data and innovation efforts across R&D
Links end-user needs to strategy and governance
Formulates Focuses strategy and execution on improvements in speed, quality and cost of trials as measurements of the value of the eClinical Strategy
Looks both within and outside the industry for technology that addresses key needs and opens opportunities tied to the eClinical strategy
Builds partnerships where advantageous
Forms external collaborations with suppliers (academia, biotech and CROs), customers (regulators, payers and providers) and technology service providers
Accountable for eClinical investment prioritization and for obtaining funding for annual eClinical projects
Leads and chairs strategic initiatives in alignment with the eClinical Strategy
Facilitates eClinical governance and the refresh of the eClinical strategy biennially or on an ad hoc basis
Coordinates current and future R&D and IT priorities in order to enhance business strategies
Aligns IT strategy with R&D goals and builds a more agile clinical environment by harnessing emerging enabling technologies
Aligns senior business and IT management with regard to the strategy
Guarantees investments and operational models ensure key tenets of the strategy are met
Qualification
Required
Bachelor's in engineering, physics, mathematics, business or computer science or similar
5+ years in role as technology strategist
Proven skill in strategy development and in converting strategy to execution
Ability to influence without direct authority
Considerable experience with obtaining and maintaining key executive support
Exemplary communication and presentation skills
Record of creating value through innovation
Preferred
Master's preferred
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Long-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-23
2026-01-20
2026-01-20
Company data provided by crunchbase